Encompass Capital Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,703,151
Closed -$47.2M 62
2024
Q3
$47.2M Sell
1,703,151
-246,849
-13% -$6.18M 2.3% 16
2024
Q2
$46.5M Sell
1,950,000
-231,339
-11% -$5.43M 2.51% 13
2024
Q1
$38.4M Buy
2,181,339
+153,807
+8% +$2.27M 2.08% 16
2023
Q4
$32M Buy
+2,027,532
New +$20.9M 1.87% 17
2023
Q2
Sell
-1,935,757
Closed -$14.4M 50
2023
Q1
$14.4M Sell
1,935,757
-1,038,992
-35% -$10.3M 0.71% 38
2022
Q4
$35.1M Buy
2,974,749
+555,477
+23% +$6.35M 1.36% 23
2022
Q3
$22.3M Sell
2,419,272
-306,299
-11% -$3.71M 1.12% 31
2022
Q2
$26.9M Buy
2,725,571
+1,814,791
+199% +$36.6M 1.81% 23
2022
Q1
$31.4M Buy
910,780
+510,592
+128% +$16.6M 1.19% 19
2021
Q4
$19.9M Buy
+400,188
New +$21.1M 1% 25

Other funds holding ASPN

Encompass Capital Advisors's ASPN Position: Q4 2024 in Review

Encompass Capital Advisors sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 1,703,151 shares — an estimated $47.2M sold.

Encompass Capital Advisors first reported a position in ASPN in Q4 2021 and held it in 10 quarters. The position peaked at $47.2M in Q3 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Encompass Capital Advisors reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Encompass Capital Advisors sold 1,703,151 Aspen Aerogels shares in Q4 2024, an estimated $47.2M.
  • Encompass Capital Advisors first reported a position in Aspen Aerogels in Q4 2021 and held it in 10 quarters.
  • Encompass Capital Advisors's Aspen Aerogels position peaked at $47.2M in Q3 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Encompass Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.